Stryker Corp

SYK is in a Stage 2 advancing regime with higher highs and higher lows, supported by the active Devil’s Bargain continuation pattern and rising EMAs. Recent pullbacks into the 9/21 EMA zone are being absorbed, creating a favorable entry point now. Short-term trends remain up, and no overbought conditions are evident. The long-term uptrend remains intact, underpinning structural bullishness.

• ↑Q1 organic sales rose 10.1% YoY; full-year organic growth guidance lifted to 8–9.5%.
• ↑Adjusted EPS hit $2.84 (+13.6% YoY); gross margin improved to 65.5%, operating margin to 22.9%.
• ↓Cyber breach disrupted operations, slowing medical segment sales rebound.